The Road to 2025: Delivering Next Generation Alzheimer’s Treatments Increasing Understanding and Collaboration Between Industry, Regulators and Payers

Last week, global stakeholders convened for the third annual Lausanne Workshop to identify, address and overcome barriers on the road to stopping Alzheimer’s by 2025. Alzheimer’s experts from government, industry, patient advocacy, regulation, public policy and academia learned lessons from those closest to Alzheimer’s disease as well as experts in other disease areas. Their goal was to challenge traditional approaches to care, drug development, regulatory and market access issues.

Read the full press release here

View the event program here